People

Richard I. Fisher, MD, has been named president and CEO of Fox Chase Cancer Center in Philadelphia, PA, which is part of the Temple University Health System, and will also hold the title of cancer center director of Fox Chase. He succeeds Michael Seiden, MD, PhD.

Before joining Fox Chase as its executive vice president in March, Fisher was vice president for strategic and program development and a professor of medicine at the University of Rochester Medical Center. In addition, he served as director of the James P. Wilmot Cancer Center at the University of Rochester School of Medicine and Dentistry and director of cancer services for the Strong Health System, all in Rochester, NY.

Fisher has held several national leadership positions in oncology. For the past 28 years, he served as chair of the Lymphoma Committee of SWOG. He has also served as chair of the Lymphoma Research Foundation Scientific Advisory Board and as a member of the National Cancer Institute's Lymphoma Steering Committee.

Margaret K. Offermann, MD, PhD, began a 1-year term as president of the Federation of American Societies for Experimental Biology (FASEB) on July 1. A federation of 27 life sciences organizations that collectively have more than 100,000 members, FASEB strives to improve health by promoting education in biologic and biomedical sciences and by advocating for the biomedical research community in Washington, DC.

Offermann is a managing partner at the Salutramed Group, Inc., a consulting firm for life sciences companies in Atlanta, GA. Previously, she was deputy national vice president for research at the American Cancer Society. She has also been a professor of hematology and oncology at Atlanta's Emory University School of Medicine and associate director of its Winship Cancer Institute.

For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.